The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries

Surbhi Grover; Katie E. Lichter; Anna Likhacheva; Joanne W. Jang; Matthew S. Ning; Tyler P. Robin; William Small; Rajat J. Kudchadker; Jamema Swamidas; Supriya Chopra; Bhavana Rai; Sunil Dutt Sharma; Daya N. Sharma; Thayalan Kuppusamy; Ruijie Yang; Daniel Berger; Lisbeth Cordero Mendez; Scott Glaser; Delnora L. Erickson; Junzo Chino; Firas Mourtada; May Abdel-Wahab; Anuja Jhingran; Hannah Simonds; Umesh Mahantshetty

doi:10.1016/j.brachy.2023.07.003

The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries

Surbhi Grover, Katie E. Lichter, Anna Likhacheva, Joanne W. Jang, Matthew S. Ning, Tyler P. Robin, William Small, Rajat J. Kudchadker, Jamema Swamidas, Supriya Chopra, Bhavana Rai, Sunil Dutt Sharma, Daya N. Sharma, Thayalan Kuppusamy, Ruijie Yang, Daniel Berger, Lisbeth Cordero Mendez, Scott Glaser, Delnora L. Erickson, Junzo ChinoFiras Mourtada, May Abdel-Wahab, Anuja Jhingran, Hannah Simonds, Umesh Mahantshetty

Research output: Contribution to journal › Article › peer-review

Abstract

PURPOSE: The global cervical cancer burden is disproportionately high in low- and middle-income countries (LMICs), and outcomes can be governed by the accessibility of appropriate screening and treatment. High-dose-rate (HDR) brachytherapy plays a central role in cervical cancer treatment, improving local control and overall survival. The American Brachytherapy Society (ABS) and Indian Brachytherapy Society (IBS) collaborated to provide this succinct consensus statement guiding the establishment of brachytherapy programs for gynecological malignancies in resource-limited settings. METHODS AND MATERIALS: ABS and IBS members with expertise in brachytherapy formulated this consensus statement based on their collective clinical experience in LMICs with varying levels of resources. RESULTS: The ABS and IBS strongly encourage the establishment of HDR brachytherapy programs for the treatment of gynecological malignancies. With the consideration of resource variability in LMICs, we present 15 minimum component requirements for the establishment of such programs. Guidance on these components, including discussion of what is considered to be essential and what is considered to be optimal, is provided. CONCLUSIONS: This ABS/IBS consensus statement can guide the successful and safe establishment of HDR brachytherapy programs for gynecological malignancies in LMICs with varying levels of resources.

Original language	English (US)
Pages (from-to)	716-727
Number of pages	12
Journal	Brachytherapy
Volume	22
Issue number	6
DOIs	https://doi.org/10.1016/j.brachy.2023.07.003
State	Published - Nov 1 2023
Externally published	Yes

Keywords

Brachytherapy
Cervix cancer
Consensus guidelines
Global oncology
Implementing new treatment techniques
Patient safety
Resource-limited setting
Uterine cancer

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.brachy.2023.07.003

Fingerprint

Dive into the research topics of 'The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries'. Together they form a unique fingerprint.

Cite this

Grover, S., Lichter, K. E., Likhacheva, A., Jang, J. W., Ning, M. S., Robin, T. P., Small, W., Kudchadker, R. J., Swamidas, J., Chopra, S., Rai, B., Sharma, S. D., Sharma, D. N., Kuppusamy, T., Yang, R., Berger, D., Mendez, L. C., Glaser, S., Erickson, D. L., ... Mahantshetty, U. (2023). The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. Brachytherapy, 22(6), 716-727. https://doi.org/10.1016/j.brachy.2023.07.003

The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. / Grover, Surbhi; Lichter, Katie E.; Likhacheva, Anna et al.
In: Brachytherapy, Vol. 22, No. 6, 01.11.2023, p. 716-727.

Research output: Contribution to journal › Article › peer-review

Grover, S, Lichter, KE, Likhacheva, A, Jang, JW, Ning, MS, Robin, TP, Small, W, Kudchadker, RJ, Swamidas, J, Chopra, S, Rai, B, Sharma, SD, Sharma, DN, Kuppusamy, T, Yang, R, Berger, D, Mendez, LC, Glaser, S, Erickson, DL, Chino, J, Mourtada, F, Abdel-Wahab, M, Jhingran, A, Simonds, H & Mahantshetty, U 2023, 'The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries', Brachytherapy, vol. 22, no. 6, pp. 716-727. https://doi.org/10.1016/j.brachy.2023.07.003

@article{d2c386c68a0843d3a737442698a7f582,

title = "The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries",

abstract = "PURPOSE: The global cervical cancer burden is disproportionately high in low- and middle-income countries (LMICs), and outcomes can be governed by the accessibility of appropriate screening and treatment. High-dose-rate (HDR) brachytherapy plays a central role in cervical cancer treatment, improving local control and overall survival. The American Brachytherapy Society (ABS) and Indian Brachytherapy Society (IBS) collaborated to provide this succinct consensus statement guiding the establishment of brachytherapy programs for gynecological malignancies in resource-limited settings. METHODS AND MATERIALS: ABS and IBS members with expertise in brachytherapy formulated this consensus statement based on their collective clinical experience in LMICs with varying levels of resources. RESULTS: The ABS and IBS strongly encourage the establishment of HDR brachytherapy programs for the treatment of gynecological malignancies. With the consideration of resource variability in LMICs, we present 15 minimum component requirements for the establishment of such programs. Guidance on these components, including discussion of what is considered to be essential and what is considered to be optimal, is provided. CONCLUSIONS: This ABS/IBS consensus statement can guide the successful and safe establishment of HDR brachytherapy programs for gynecological malignancies in LMICs with varying levels of resources.",

keywords = "Brachytherapy, Cervix cancer, Consensus guidelines, Global oncology, Implementing new treatment techniques, Patient safety, Resource-limited setting, Uterine cancer",

author = "Surbhi Grover and Lichter, {Katie E.} and Anna Likhacheva and Jang, {Joanne W.} and Ning, {Matthew S.} and Robin, {Tyler P.} and William Small and Kudchadker, {Rajat J.} and Jamema Swamidas and Supriya Chopra and Bhavana Rai and Sharma, {Sunil Dutt} and Sharma, {Daya N.} and Thayalan Kuppusamy and Ruijie Yang and Daniel Berger and Mendez, {Lisbeth Cordero} and Scott Glaser and Erickson, {Delnora L.} and Junzo Chino and Firas Mourtada and May Abdel-Wahab and Anuja Jhingran and Hannah Simonds and Umesh Mahantshetty",

note = "Publisher Copyright: {\textcopyright} 2023 American Brachytherapy Society",

year = "2023",

month = nov,

day = "1",

doi = "10.1016/j.brachy.2023.07.003",

language = "English (US)",

volume = "22",

pages = "716--727",

journal = "Brachytherapy",

issn = "1538-4721",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries

AU - Grover, Surbhi

AU - Lichter, Katie E.

AU - Likhacheva, Anna

AU - Jang, Joanne W.

AU - Ning, Matthew S.

AU - Robin, Tyler P.

AU - Small, William

AU - Kudchadker, Rajat J.

AU - Swamidas, Jamema

AU - Chopra, Supriya

AU - Rai, Bhavana

AU - Sharma, Sunil Dutt

AU - Sharma, Daya N.

AU - Kuppusamy, Thayalan

AU - Yang, Ruijie

AU - Berger, Daniel

AU - Mendez, Lisbeth Cordero

AU - Glaser, Scott

AU - Erickson, Delnora L.

AU - Chino, Junzo

AU - Mourtada, Firas

AU - Abdel-Wahab, May

AU - Jhingran, Anuja

AU - Simonds, Hannah

AU - Mahantshetty, Umesh

PY - 2023/11/1

Y1 - 2023/11/1

N2 - PURPOSE: The global cervical cancer burden is disproportionately high in low- and middle-income countries (LMICs), and outcomes can be governed by the accessibility of appropriate screening and treatment. High-dose-rate (HDR) brachytherapy plays a central role in cervical cancer treatment, improving local control and overall survival. The American Brachytherapy Society (ABS) and Indian Brachytherapy Society (IBS) collaborated to provide this succinct consensus statement guiding the establishment of brachytherapy programs for gynecological malignancies in resource-limited settings. METHODS AND MATERIALS: ABS and IBS members with expertise in brachytherapy formulated this consensus statement based on their collective clinical experience in LMICs with varying levels of resources. RESULTS: The ABS and IBS strongly encourage the establishment of HDR brachytherapy programs for the treatment of gynecological malignancies. With the consideration of resource variability in LMICs, we present 15 minimum component requirements for the establishment of such programs. Guidance on these components, including discussion of what is considered to be essential and what is considered to be optimal, is provided. CONCLUSIONS: This ABS/IBS consensus statement can guide the successful and safe establishment of HDR brachytherapy programs for gynecological malignancies in LMICs with varying levels of resources.

AB - PURPOSE: The global cervical cancer burden is disproportionately high in low- and middle-income countries (LMICs), and outcomes can be governed by the accessibility of appropriate screening and treatment. High-dose-rate (HDR) brachytherapy plays a central role in cervical cancer treatment, improving local control and overall survival. The American Brachytherapy Society (ABS) and Indian Brachytherapy Society (IBS) collaborated to provide this succinct consensus statement guiding the establishment of brachytherapy programs for gynecological malignancies in resource-limited settings. METHODS AND MATERIALS: ABS and IBS members with expertise in brachytherapy formulated this consensus statement based on their collective clinical experience in LMICs with varying levels of resources. RESULTS: The ABS and IBS strongly encourage the establishment of HDR brachytherapy programs for the treatment of gynecological malignancies. With the consideration of resource variability in LMICs, we present 15 minimum component requirements for the establishment of such programs. Guidance on these components, including discussion of what is considered to be essential and what is considered to be optimal, is provided. CONCLUSIONS: This ABS/IBS consensus statement can guide the successful and safe establishment of HDR brachytherapy programs for gynecological malignancies in LMICs with varying levels of resources.

KW - Brachytherapy

KW - Cervix cancer

KW - Consensus guidelines

KW - Global oncology

KW - Implementing new treatment techniques

KW - Patient safety

KW - Resource-limited setting

KW - Uterine cancer

UR - http://www.scopus.com/inward/record.url?scp=85171774246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85171774246&partnerID=8YFLogxK

U2 - 10.1016/j.brachy.2023.07.003

DO - 10.1016/j.brachy.2023.07.003

M3 - Article

C2 - 37704540

AN - SCOPUS:85171774246

SN - 1538-4721

VL - 22

SP - 716

EP - 727

JO - Brachytherapy

JF - Brachytherapy

IS - 6

ER -

The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this